Why is Saroja Pharma In falling/rising?

As of 18-Sep, Saroja Pharma Industries India Ltd is currently priced at 47.45, reflecting an increase of 0.4, or 0.85%. The stock has shown mixed performance recently; while it is currently above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages. The stock has underperformed significantly over the past year, with a decline of 20.05% compared to a market return of only 0.18%. Additionally, there has been a notable decrease in investor participation, as evidenced by a 50% drop in delivery volume on September 12, which may indicate waning interest among investors.
In the broader market context, Saroja Pharma's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.67% over the past week and 2.20% over the past month. This suggests that while the overall market is experiencing upward momentum, Saroja Pharma is lagging behind, contributing to its negative sentiment. The stock's year-to-date performance is particularly concerning, with a decline of 20.92% compared to the Sensex's gain of 7.52%, highlighting a significant underperformance relative to the market.